composition in preparing drugs for secondary prevention of coronary heart disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9072745
APP PUB NO 20130196005A1
SERIAL NO

13813827

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is the use of a Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of the Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TASLY PHARMACEUTICAL GROUP CO LTDTIANJIN 300410

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guo, Zhixin Tianjin, CN 14 39
Liu, Weiwei Tianjin, CN 62 1374
Luo, Ruizhi Tianjin, CN 4 3
Sun, He Tianjin, CN 64 167
Wu, Naifeng Tianjin, CN 22 48
Yan, Kaijing Tianjin, CN 18 20
Yan, Xijun Tianjin, CN 28 50
Zhao, Libin Tianjin, CN 3 12
Zhu, Guoguang Tianjin, CN 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00